Wednesday, August 29, 2007

Generex Biotechnology to collaborate with Rochester University on ...

Generex Biotechnology to collaborate with Rochester University on ...
Generex Biotechnology Corporation announced that its wholly-owned
immunotherapy subsidiary, Antigen Express, Inc., has entered into an
agreement with the University of Rochester as part of the ...



http://www.bionity.com/news/e/67865/?WT.mc_id=ca0068



Biotech News
AZhttp, Inc.
Biotechnology Marketing

Developing of CubaâEURO(tm)s biotechnology is up and going Cuba Headlines -

Developing of CubaâEURO(tm)s biotechnology is up and going Cuba Headlines -
Ciudad Habana,Habana,Cuba CubaâEURO(tm)s biotechnology registered growths of
75 and 87 million pesos in the last two years, while important results are
being achieved during the present ...

http://www.cubaheadlines.com/2007/08/28/5412/developing_of_cuba_s_biotechnology_is_up_and_going.html>




Biotech News
AZhttp, Inc.
Biotechnology Marketing

Seminar on biotechnology

Seminar on biotechnology
Chennai Online - Chennai,India
The British Council, in partnership with the Centre for Biotechnology, Anna
University, Chennai, is organising a two-day seminar on 'Biotechnology: UK
and ...


http://www.chennaionline.com/education/Events/Aug2007/08article09.asp>



Biotech News
AZhttp, Inc.
Biotechnology Marketing

Grants to fund cancer research

Grants to fund cancer research
Asheville Citizen-Times - NC,USA
Since 1986, UNCA has received 10 grants from the NC Biotechnology Center,
totaling $463064, according to Jim Shamp, a center spokesman. ...

http://www.citizen-times.com/apps/pbcs.dll/article?AID=200770828107>



Biotech News
AZhttp, Inc.
Biotechnology Marketing

Olympus Establishes Imaging Laboratory with National Center for ...

Olympus Establishes Imaging Laboratory with National Center for ...
HULIQ - Hickory,NC,USA
In recent years, India has also built an international profile in life
science fields, such as pharmacology and biotechnology. In 2005, the
Department of ...

http://www.huliq.com/32041/olympus-establishes-imaging-laboratory-with-natio
nal-center-for-biological-science>



Biotech News
AZhttp, Inc.
Biotechnology Marketing

Tuesday, August 28, 2007

Biotechnology Business: Indevus Announces Receipt of $49.9 Million ...

Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced that it has received a
$49.9 million milestone payment from Esprit Pharma, the Company's partner in
the US for SANCTURA(R)...

http://www.newsrx.com/articles/684235.html


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Exploring Careers in Biotechnology

By Randy Nichols
Choosing a career is a very exciting, yet challenging task. There are many
different fields that a person can choose from when deciding how they would
like to spend most of their time in life. It is essential to select a career
that ...

http://www.careeradviceblog.com/2007/08/27/exploring-careers-in-biotechnology/


Biotech News
AZhttp, Inc.
Biotechnology Marketing

A Bioreactor Model of Mouse Tumor Progression

The present study represents an investigation of a novel stirred bioreactor
for culture of a transformed cell line under defined hydrodynamic conditions
in vitro. Cell colonies of the EL-4 mouse lymphoma cell line grown for the
first ...


http://hindawi.com/GetArticle.aspx?doi=10.1155/2007/32754

Journal of Biomedicine and Biotechnology


Biotech News
AZhttp, Inc.
Biotechnology Marketing

MARD bolsters biotechnology in plan for aquaculture industry

Vietnam - August 27, 2007 - The Ministry of Agriculture and Rural
Development has approved a plan to increase the use of bio-technology to
boost the aquaculture industry.


http://www.growfish.com.au/content.asp?ContentId=9953


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Ex-boss says Coughlin made 'every effort' to follow ethics rules

Boston Herald - United States Coughlin filed a disclosure July 24, when he
recused himself from matters related to the life sciences and biotechnology
industries. ...


http://news.bostonherald.com/localPolitics/view.bg?articleid=1019400


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biogen Idec Climbs After FTC Approves Icahn Stock Buy

CNNMoney.com - USA The FTC announcement comes just days after Icahn first
revealed an interest in Biogen, one of the industry's oldest biotechnology
companies. On Aug...

http://money.cnn.com/news/newsfeeds/articles/djhighlights/200708262143DOWJON


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Monday, August 27, 2007

Biotech News

Biotech News

Eye on DNA Headlines for 26 August 2007
By Hsien
Biotech Partners supports students interested in biotechnology by providing
them internships and co-op jobs in biotechnoloogy. More in the San Francisco
Chronicle. On Tuesday, the SF Chronicle looked at home DNA tests. ...
http://www.eyeondna.com/2007/08/26/eye-on-dna-headlines-for-26-august-2007/

Generex Biotechnology to Collaborate With Leading Investigator At ...
Generex Biotechnology Corporation announced today that its wholly-owned
immunotherapy subsidiary, Antigen Express, Inc., has entered into an
agreement with the University of Rochester as part of the Antigen ... via
PrimeNewswire.
http://www.topix.com/science/biology/2007/08/generex-biotechnology-to-colla
borate-with-leading-investigator-at-the?fromrss=1>


AZhttp, Inc.
Biotechnology Marketing

Stem cells proved effective in regrowing heart muscle

MARD bolsters biotechnology in plan for aquaculture industry Viet Nam News -
Hanoi,Vietnam HCM CITY -- The Ministry of Agriculture and Rural Development
has approved a plan to increase the use of bio-technology to boost the
aquaculture industry. ...
http://vietnamnews.vnagency.com.vn/showarticle.php?num=02AGR250807>

Stem cells proved effective in regrowing heart muscle in rats Seattle Times
- United States After four years of research, Murry and his colleagues at
Geron, a biotechnology company in Menlo Park, Calif., had a breakthrough:
They found a process to ...
http://seattletimes.nwsource.com/html/localnews/2003854582_webstemcells26m.



Biotech News
AZhttp, Inc.
Biotechnology Marketing

Sunday, August 26, 2007

Biotech News

Roche - Principal Quality Specialist, Pre-Production (oakland ...
As the pioneers of Polymerase Chain Reaction (PCR) technology, Roche Molecular Diagnostics has embarked on an incredible adventure that has not only launched the use of reliable DNA-based tests into laboratories worldwide, ...
http://www.biotechjobspro.com/biotech-543/roche-principal-quality-specialist-pre-production-oakland-downtown.html

Career's in biotech.

Unabashedly stealing these links from "In the Pipeline" where you should be reading anyway. Faseb did a study on biomedical sciences and what is going on with jobs. The summary is here. The basic take home for me was that there are a ...
http://somestuffiwrite.blogspot.com/2007/08/careers-in-biotech.html

Biotech News
AZhttp, Inc.
Internet Marketing
Biotechnology Marketing

Biotech News

AZhttp, Inc.
Internet Marketing

Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc "Todd has exceptional technical, financial and operating experience, and the energy and strategic vision to lead eBioscience through its next stage of growth." Dr. Nelson comes to eBioscience from Invitrogen Corporation where he was ...
http://www.topix.com/business/biotech/2007/08/todd-r-nelson-named-chief-executive-officer-of-ebioscience-inc?fromrss=1


Biotech News

Biotech Jobs

Phoenix Jobs - Including Biotech Jobs

Phoenix Jobs

Biotech News

ARIZONA

A new page promoting Phoenix Jobs resources has been added to the SJN Phoenix Jobs website.

Some of the featured resources include Jobing.com, the Scottsdale Job Network Phoenix Jobs Job Board and the City of Phoenix Jobs listings at Phoenix.gov.

Please stop by and take a look. We think you will find some of these SJN resources valuable in your job search.Plan to visit us at our next meeting on TUES, SEPT 4, 2007

Guest speaker:
Robert Meade,
Recruiting Manager
DBL Distributing LLC
(480) 422-7763

http://www.dbldistributing.com/

Learn about this actively growing Scottsdale company, its history, products and services, growth plans, and staffing needs. Rob will discuss strategies to learn the skills hiring managers are seeking and how to communicate those skills effectively during an interview.

Meetings are held on the first and third TUESDAY mornings, from 9:00-11:30 AM.

We are a community group that meets at and uses space provided free of charge by:

Temple Chai
4645 East Marilyn Road
Phoenix, Arizona 85032

Temple Chai is centrally located just east of the Piestawa Freeway (Route 51) and south of the loop 101. Marilyn Road is just west of Tatum Blvd. between Thunderbird and Greenway Roads. Click here for a location map on MapQuest

Meetings are open to the public.

There are no meeting fees or membership dues.We appreciate donations to cover our operating costs.SJN is a non-profit community group of business leaders and volunteers. We are not a job placement forum, and we do not match candidates to openings nor do we send resumes to employers or recruiters. There is no guarantee of employment either directly through this group or as a result of association with SJN.We do, however, provide education in the job search process and all attendees have the opportunity to meet and work with people who offer support and guidance during employment transition.


AZhttp, Inc.


Internet Marketing

Icahn May Boost Biogen Stake

Biotech News
AZhttp, Inc.

Icahn May Boost Biogen Stake, Forecasts Takeover (Update1) Bloomberg - USA
5 US biotech company ranked by sales, with $2.7 billion in revenue in 2006, based on data compiled by Bloomberg. It follows Amgen Inc., Genentech, ...
http://www.bloomberg.com/apps/news?pid=20601087&sid=arKcUDBprzgM&refer=home


Biotechnology Marketing

Thursday, August 02, 2007

TGen Awarded $1 Million from the W.M. Keck Foundation

Biotech News
AZhttp, Inc.


TGen Awarded $1 Million from the W.M. Keck Foundation


Grant will fund research in systems biology

08-02-2007

Phoenix, AZ, August 2, 2007--The Translational Genomics Research Institute (TGen) has announced the award of a $1 million grant from the W. M. Keck Foundation to fund a project designed to shed light on the regulation of cellular processes at a genomic level. The project is a joint endeavor between researchers at TGen and Texas A&M University.
The project is based on an emerging field called systems biology that combines engineering, mathematics and biology to further our understanding of the underlying signal processing that takes place within cells.

TGen's infrastructure is already in place to carry out these types of detailed systems biology experiments. Dr. Michael Bittner, Co-Director and Senior Investigator of TGen's Computational Biology Division, will lead the project.

"This project allows us to further our knowledge of cellular 'control systems' and to build new technologies that measure and analyze the processes going on both inside the cell and between cells," said Dr. Bittner. "In this way, we will develop biological versions of the methods engineers use to study man-made systems, such as telecommunications and computing systems."

Dr. Bittner will collaborate with Dr. Edward Dougherty, Co-Director and Adjunct Senior Investigator of TGen's Computational Biology Division and Professor at the Department of Electrical Engineering at Texas A&M University.

The W.M. Keck Foundation, one of the nation's largest philanthropic organizations, supports pioneering discoveries in science, engineering and medical research.

"This gift from the W. M. Keck Foundation represents far more to TGen than the funding of an important research opportunity," said Michael Bassoff, President of the TGen Foundation. "It is recognition by the W. M. Keck Foundation of the leading edge science that is conducted by TGen and its collaborators, and the critical impact we will make on the future of medical treatments for patients with life threatening diseases."

# # #

About TGen
The Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization, is focused on developing earlier diagnoses and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen's research is based on personalized medicine and the institute plans to accomplish its goals through robust and disease-focused research.

About the W.M. Keck Foundation
Based in Los Angeles, the W. M. Keck Foundation was established in 1954 by the late W. M. Keck, founder of the Superior Oil Company. The Foundation’s grant making is focused primarily on pioneering efforts in the areas of medical research, science and engineering. The Foundation also maintains a program to support undergraduate science and humanities education and a Southern California Grant Program that provides support in the areas of health care, civic and community services, education and the arts, with a special emphasis on children.


Biotechnology Marketing

Biotechnology News

Biotech News
AZhttp, Inc.



DC biotech being snatched up by Australian firm Washington Business Journal - Washington,DC,USA by Vandana Sinha An Australian company is acquiring Hamilton Pharmaceuticals Inc., one of DC's only biotech companies, in a stock deal worth $4.4 million. ...
http://washington.bizjournals.com/washington/stories/2007/07/30/daily12.html?jst=b_ln_hl


Brain-drain: How new law can help
Daily Nation (subscription) - Nairobi,Kenya The biotech employers -- the likes of the Kenya Agricultural Institute (Kari), international research organisations, and private sector organisations -- are ...
http://www.nationmedia.com/dailynation/nmgcontententry.asp?category_id=25&newsid=103579

Biotech lab expansion hampered by site dispute New Haven Register (subscription) - New Haven,CT,USA All Carter Winstanley had to do to find a logical place to expand his complex of biotech labs was look out the window. But a dispute between the city and ...
http://www.nhregister.com/site/news.cfm?newsid=18654056&BRD=1281&PAG=461&dept_id=7576&rfi=6

Wednesday's Top Biotech & Medical Stocks By HSA(HSA) by HS Ayoub BioHealth Investor Biotechnology PROTALIX BIOTHERAPEU [PLX] +26.30% REXAHN PHARMACEUTICL [RXHN.OB] +19.35% SAVIENT PHARM INC [SVNT] +17.40% POLYDEX PHARM LTD [POLXF] +16.25% VIROPHARMA INC [VPHM] +11.91% Diagnostic. ...
http://biohealthinvestor.com/2007/08/wednesdays-top-biotech-medical-stocks.html
BioHealth Investor

Quote of the day from The Personal Genome By Ricardo Vidal I just loved this post by Jason from The Personal Genome regarding open access to scientific and medical literature. "It is easy to attack journalists and bloggers for getting their facts wrong, but we're living in an information ...
http://my.biotechlife.net/2007/08/01/quote-of-the-day-from-the-personal-genome/
My Biotech Life
http://my.biotechlife.net

Sinovac Biotech Ltd. Enters Exclusive Promotion Service Agreement ...
1 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, today announced it has entered into an Exclusive Promotion Service Agreement with GlaxoSmithKline (China) Investment Co., Ltd. ...
http://www.biospace.com/news_story.aspx?StoryID=64945&full=1>
BioSpace.com Featured News and Stories


Biotechnology Marketing

Biotech news

J&J cuts 600 local biotech jobs
San Jose Mercury News - CA, USA
At least 600 Bay Area employees will lose their jobs and 200 others will be transferred to other locations because of a major cost-cutting move announced by ...



Burrill Reports Biotech Hit By Market Jitters in July Earthtimes.org - USA
1 -- "Biotech had to weather a bumpy ride in the wake of nervous investors and skittish general markets," said G. Steven Burrill, CEO, Burrill & Company, ...
http://www.earthtimes.org/articles/show/news_press_release,151036.shtml


IIR ME events to focus on biotech, infection control investments Khaleej Times - Dubai,United Arab Emirates BY JOSE FRANCO DUBAI -- Stressing the importance of having national and regional emergency preparedness programmes, the world's leading human capital company ...
http://www.khaleejtimes.com/DisplayArticleNew.asp?xfile=data/business/2007/August/business_August31.xml§ion=business&col=


Biotech News
AZhttp, Inc.
Biotechnology Marketing

Biotech news

Biotech News
AZhttp, Inc.

GPC Biotech: satraplatin approval delay could prove costly Pharmaceutical Business Review - USA By Tom Gray GPC Biotech has withdrawn the New Drug Application for its prostate cancer drug satraplatin, following an advisory panel's recommendation that ...
http://www.pharmaceutical-business-review.com/article_feature.asp?guid=DACE4ECD-1A70-4FA2-A8C7-006BA15B29FD

Region renews biotech hunt
Vero Beach Press-Journal (subscription) - Vero Beach,FL,USA He added the foundation isn't the only biotech player that has expressed interest in locating to the 8200-acre community in western Port St. Lucie.
...
http://www.tcpalm.com/news/2007/aug/02/30region-renews-biotech-hunt



Biotechnology Marketing

Wednesday, August 01, 2007

Study Reveals Genetic Clues about Lou Gehrig's Disease

Biotech News
AZhttp, Inc.


Study Reveals Genetic Clues about Lou Gehrig's Disease


Discovery opens a new avenue for ALS research

08-01-2007

PHOENIX, AZ, August 1, 2007 -- A comprehensive scan of the human genome by researchers at the Translational Genomics Research Institute (TGen) has identified more than 50 genetic abnormalities in people with sporadic amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), according to a study published in today’s online issue of the New England Journal of Medicine. The identified differences implicate genes that are likely to play a role in nerve function, offering a new avenue for ALS therapy development.
ALS is a progressive neurological disorder that leads to paralysis and death in three to five years. It has baffled researchers for nearly 140 years.

After screening DNA samples from over 1,250 people with and over 2,000 people without sporadic ALS, TGen researchers identified genes that are involved in maintaining motor neuron connections at the nerve-muscle junction, and allowing normal voluntary movement.

Dr. Dietrich Stephan, Director of TGen’s Neurogenomics Division and the study's principle investigator, has validated the study’s results by analyzing all of the available data in the public domain. Additionally, Dr. Stephan and his research team have refined the biological mechanism that predisposes individuals to ALS in order to move genetic discoveries more quickly to the clinic.

"ALS is a horrific disorder that very quickly leads to complete paralysis," said Dr. Stephan. "This is the first study to find consistent genetic changes that predispose to this disorder, giving researchers new leads for the development of therapeutics."

The study was funded by a $652,000 grant from the Muscular Dystrophy Association’s (MDA) Augie's Quest, a fast-track ALS research program, in collaboration with TGen. Blood donated for the study came from the MDA/ALS Center at Methodist Neurological Institute in Houston, the Forbes Norris MDA/ALS Center at California Pacific Medical Center in San Francisco, the MDA/ALS Center at the University of Pittsburgh, and the Eleanor and Lou Gehrig MDA/ALS Center at Columbia University in New York, as well as a dozen other collection sites comprising the Western ALS Study Group (WALS) throughout the United States.

# # #

About TGen
TGen is a nonprofit 501(c)(3) organization focused on developing earlier diagnoses and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases. TGen's research is based on personalized medicine. The institute plans to accomplish its goals through robust and disease-focused research.

About MDA
MDA (www.mda.org) is a voluntary health agency working to defeat more than 40 neuromuscular diseases through programs of worldwide research, comprehensive services and far-reaching professional and public health education. It operates 235 neuromuscular disease clinics, of which 37 are ALS-specific research and care centers, across the United States. In 2006, MDA allocated some $7 million to ALS research and another $10 million for ALS health care services. Since its inception, the Association's expenditures for ALS research and services have exceeded $190 million.

About Augie's Quest
Fitness pioneer Augie Nieto started Augie's Quest (www.augiesquest.org) in conjunction with MDA's ALS Division. Nieto is co-founder and former president of Life Fitness, and chairman of Octane Fitness. He and his wife, Lynne, serve as co-chairpersons of MDA's ALS Division. Nieto received a diagnosis of ALS in March 2005.

Biotechnology Marketing